People on the Move
Repligen
Biotech Repligen, which makes Protein A from sites in Massachussetts and Sweden, has announced its next CEO will be Tony Hunt. Repligen’s Chief Operating Officer will take over duties from current Chief Executive Walter Herlihy in May.
"We are delighted to promote our COO, Tony Hunt, a seasoned and successful bioprocessing industry executive, to the position of CEO,” said Karen Dawes, Chairwoman. “Tony joined Repligen in the spring of 2014 as Chief Operating Officer and has quickly made a very positive impact as a leader by expanding our commercial footprint and effectively integrating our acquisition of Refine Technologies into our operations."
Before joining Repligen, Hunt was President of Bioproduction at Life Technologies, later acquired by Thermo Fisher Scientific.